Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BHM-Tech is an Austrian medical technology company focused on bone conduction hearing systems and related hearing solutions for people with hearing loss. The company manufactures and sells commercial hearing devices and accessories, including bone conduction products such as Contact Forte and Apollon, and also took over support for the Sophono bone conduction product line from Medtronic in 2023. BHM-Tech operates as a commercial-stage medtech business rather than a drug-development biotech company, with its core capabilities in specialized hearing hardware, precision components, and manufacturing. In July 2024, the company was acquired by MED-EL, which positioned the transaction as a way to expand its portfolio in innovative hearing solutions. BHM-Tech remains active as part of the MED-EL group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BHM-Tech.